|
Volumn 20, Issue 2, 2014, Pages
|
Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults.
a a a a a a a a a a a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTHRAX VACCINE;
ANTIINFECTIVE AGENT;
ANTITOXIN;
IMMUNOGLOBULIN;
MONOCLONAL ANTIBODY;
RAXIBACUMAB;
ADULT;
ADULTS;
ANTHRAX;
BACILLUS ANTHRACIS;
BACTERIUM;
BIOLOGICAL WARFARE;
BIOTERRORISM AND PREPAREDNESS;
CENTERS FOR DISEASE CONTROL AND PREVENTION;
CLINICAL COMPETENCE;
CONFERENCE PAPER;
DISEASE MANAGEMENT;
DRUG EFFECT;
EXPERT PANEL MEETING;
HUMAN;
IMMUNOLOGY;
INTENSIVE CARE;
MICROBIOLOGY;
PATHOGENICITY;
PRACTICE GUIDELINE;
PREVENTION;
PUBLIC HEALTH SERVICE;
TREATMENT;
UNITED STATES;
ADULTS;
ANTHRAX;
ANTITOXIN;
BACILLUS ANTHRACIS;
BACTERIA;
BIOTERRORISM AND PREPAREDNESS;
CENTERS FOR DISEASE CONTROL AND PREVENTION;
EXPERT PANEL MEETING;
PREVENTION;
RAXIBACUMAB;
TREATMENT;
ADULT;
ANTHRAX;
ANTHRAX VACCINES;
ANTI-BACTERIAL AGENTS;
ANTIBODIES, MONOCLONAL;
ANTITOXINS;
BACILLUS ANTHRACIS;
BIOTERRORISM;
CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.);
CLINICAL COMPETENCE;
CRITICAL CARE;
DISEASE MANAGEMENT;
HUMANS;
IMMUNOGLOBULINS, INTRAVENOUS;
PRACTICE GUIDELINES AS TOPIC;
UNITED STATES;
|
EID: 84905506094
PISSN: None
EISSN: 10806059
Source Type: Journal
DOI: 10.3201/eid2002.130687 Document Type: Conference Paper |
Times cited : (186)
|
References (0)
|